AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...

Addresses the significant threat of antimicrobial resistance.

The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.

Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...

AbbVie (ABBV) announced the U.S. Food and Drug Administration approval of Emblaveo (aztreonam and avibactam). This marks the first ...

AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...

Background The Contour Neurovascular System (CNS, Stryker, Kalamazoo, MI) has a unique design that allows it to address various aneurysm morphologies, including wide-necked, irregular, and ...

Background Blebs significantly increase rupture risk of intracranial aneurysms. Radiomic analysis offers a robust characterization of the aneurysm wall. However, the unique radiomic profile of various ...

The abdominal injury that caused Naomi Osaka to retire from the Auckland final with a one-set lead over Clara Tauson less than two weeks ago struck again Friday, forcing the four-time major ...

Kyle Smelser, A host on MIX Mornings with Kyle, Bryan and Sarah said his wife, also named Sarah, suffered a brain aneurysm and multiple strokes last week. Complicating matters, Sarah is 30 weeks ...

Abdominal pain is considered chronic if it lasts for more than three months. The pain may be constant or it can come and go over the three-month period or longer. There are many health conditions, ...

Intra-Cellular Therapies ITCI signed a definitive agreement with pharma bigwig Johnson & Johnson JNJ. Per the terms, the pharma giant will acquire all outstanding shares of ITCI for $132 per share ...